We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

FDA Warns Companies Making Unauthorized Diabetes Claims For Their Products

July 23, 2013: 12:00 AM EST
The U.S. Food and Drug Administration issued warning letters to companies that make diabetes-related claims for their products. Part of the FDA’s probe into health benefits claims on products, websites, and other marketing literature, the warning letters covered products ranging from nutritional supplements to topical creams. Neuliven Health, Inc. received a warning letter for claims the company has made for its Glucocil product, including lowering fasting blood sugar levels by up to 29 percent and lowering A1c levels significantly. Also, the FDA warned PharmaTerra, Inc. for claims related to its ProBeta product, which tend to establish that the product is a drug.
Stephen DANIELLS , "FDA targets diabetes claims with raft of new warning letters", Nutra-Ingredients USA, July 23, 2013, © William Reed Business Media SAS
North America
United States of America
Legal, Legislation, Regulation, Policy
Marketing & Advertising
Products & Brands
Developed by Yuri Ingultsov Software Lab.